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In the pursuit of understanding the pathological alterations that underlie ischaemic injuries, such as vascular remodelling and
reorganisation, there is a need for recognising the capabilities and limitations of in vivo imaging techniques. us, this review
presents contemporary published research of imaging modalities that have been implemented to study postischaemic neuro-
vascular changes in small animals. A comparison of the technical aspects of the various imaging tools is included to set the
framework for identifying the most appropriate methods to observe postischaemic neurovascular remodelling. A systematic
search of the PubMed® and Elsevier’s Scopus databases identied studies that were conducted between 2008 and 2018 to explorepostischaemic neurovascular remodelling in small animal models. irty-ve relevant in vivo imaging studies are included, of
which most made use of magnetic resonance imaging or positron emission tomography, whilst various optical modalities were
also utilised. Notably, there is an increasing trend of using multimodal imaging to exploit the most benecial properties of each
imaging technique to elucidate dierent aspects of neurovascular remodelling. Nevertheless, there is still scope for further utilising
noninvasive imaging tools such as contrast agents or radiotracers, which will have the ability to monitor neurovascular changes
particularly during restorative therapy. is will facilitate more successful utility of the clinical imaging techniques in the in-
terpretation of neurovascular reorganisation over time.
1. Introduction
Oxygen is essential for the survival and basic functioning of
biological systems. A stable equilibrium between the supply
and usage of oxygen in biological systems generates oxygen
gradients, wherein areas with low concentrations of oxygen
(i.e., hypoxic regions) are situated relatively distant from the
central vasculature. ese oxygen gradients contribute to a
healthy and functioning physiology, and their dis-
turbance—for example, due to injury or disease—can confer
debilitating eects on the functioning physiology [1]. Neural
ischaemia is typically a hypoxic phenomenon, usually the
result of some kind of traumatic injury or vascular dis-
ruption, developing from a deciency in blood ow to brain
tissue. is interrupted circulatory ow then triggers
changes in the brain’s metabolic processes [2]. Immediately
following ischaemic injury, a series of biochemical reactions
ensue within the brain, which are collectively termed the
ischaemic cascade. e ischaemic cascade involves bio-
chemical energy depletion and the inability tomaintain ionic
gradients across cell membranes due to the restriction in
blood supply. is eventually triggers cytotoxic and vaso-
genic oedema, as well as apoptotic and necrotic processes,
which ultimately result in the deterioration of healthy brain
tissue [3–5]. is cascade is elicited in patients who expe-
rience ischaemic stroke (Figure 1) [6].
One of the outcomes of an ischaemic stroke is the
structural alteration of blood vessels to accommodate for the
changes in haemodynamic conditions. is remodelling of
the vasculature involves alterations in angiogenesis, the
development of new blood vessels from preexisting ones;
angionecrosis, the death of blood vessels or of the walls of
blood vessels; migration of cells that compose blood
vessels; and production and/or degradation of the
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extracellular matrix. Essentially, vascular remodelling is
dependent on an interplay of haemodynamic stimuli,
growth factors, and vasoactive substances [7]. As a result of
the inclusion of a wide range of processes, it is essential to
brieﬂy address that the terminology of vascular “remod-
elling” may be used interchangeably with “alterations,”
“plasticity,” “reorganisation,” “rearrangement,” or other
similar keywords in the literature. *e biological process
involving this interplay is described in Figure 2, wherein
the detection and relay of haemodynamic signals ulti-
mately lead to vascular reorganisation.
Knowledge of the overall neurovasculature is useful
for distinguishing the blood vessel or group of vessels that
may be associated with an ischaemic stroke; unusual
vascular patterns can then be attributed to other diseases,
such as seizures, intracerebral haemorrhage, or brain
tumours [8]. *e functional deﬁcits resulting from an
ischaemic stroke are dependent on the cerebral arter-
ies—and thus the brain regions—that are disrupted [6].
*e cerebral hemispheres are each supplied by the pos-
terior, middle, and anterior cerebral arteries. *e poste-
rior cerebral arteries originate from the basilar artery and
supply the medial and posterior regions of the temporal
and occipital lobes, as well as the thalamus and brainstem
regions. *e middle cerebral arteries, which originate
from the supraclinoid internal carotid, supply the anterior
and lateral regions of the temporal lobes and lateral re-
gions of the parietal and frontal lobes. *e anterior ce-
rebral arteries also originate from the supraclinoid
internal carotid and supply the anterior regions of the
basal ganglia, as well as the medial regions of the parietal
and frontal lobes [9].
Imaging techniques play a signiﬁcant role in clinical re-
search; they are crucial for enhanced visualisation to better
understand biological processes. *e world’s ﬁrst images of
human brain metabolism were acquired via continuous in-
halation of positron-emitting radioactive oxygen ([15O]) to
study the neurovascular distribution and accumulation of
oxygen [10, 11]. Since then, our understanding of neuro-
vascular dynamics has signiﬁcantly progressed; various
neuroimaging techniques with additional advantages, such as
improved spatial resolution and the capacity for longitudinal
imaging, are implemented in preclinical research and clinical
practice. Neuroimaging (i.e., the use of imaging for neuro-
logical structures) can serve two purposes: (1) to diﬀerentiate
amongst various morphological structures and (2) to visualise
Ischaemic injury
Hypoxia Breakdown of BBB
Depletion of ATP Flooding of fluids into
extracellular space
Loss of balance between energy
supply and consumption Vasogenic oedema
Cell depolarisation Release of glutamate and
free radicals
Influx of Na+, Ca2+, and water Disruption of mitochondrial
membrane
Cytotoxic oedema Apoptosis
Death of astrocytes,
oligodendroglia, and microglia
Necrosis
Removal of infarcted tissue by
macrophages
Encephalomalacia
Figure 1: Ischaemic cascade. *e cascade involves a series of events that follow ischaemic injury to the brain, such as that due to stroke.
Eventually, this results in the softening or loss of brain tissue (i.e., encephalomalacia). BBB, blood-brain barrier; ATP, adenosine triphosphate.
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functional changes in neural plasticity following injury [6].
One such example involves imaging patients immediately
after the onset of a stroke and posttraumatically at regular
intervals. It is well established that patients who experience
ischaemic stroke subsequently undergo vascular remodelling
within the brain [2, 5, 7]. Studies of stroke in humans are
limited because of the diﬃculties in collecting postmortem
tissue samples when neuronal death occurs. *us, neural
ischaemia research is largely built upon information gathered
from studies of animal models. When ischaemia is induced in
experimental rodent models, for example, blood ﬂow is
disrupted to restrict the delivery of oxygen and glucose to
neurons, eventually causing a depletion in biochemical energy
[1, 12].
*e aim of this review is to provide a guide to current
imaging techniques being used to explore neurovascular
remodelling in a preclinical in vivo setting. *is review will
contribute to the following:
(i) Identify and distinguish preclinical imaging options
used in the last 10 years
(ii) Compare these techniques across common
parameters
(iii) Explore the potential applications of novel advances
in imaging technologies
(iv) Discuss how these imaging techniques could be
translated to improve the medical management of
ischaemic stroke
2. Materials and Methods
2.1. Search Strategy. *e PubMed® and Elsevier’s Scopusonline databases were used to retrieve journal papers. Titles,
keywords, and abstracts were scanned for the search ter-
minology using the search engines. *e citations and ref-
erences of any retrieved papers were also scanned for any
relevant literature that may have been missed in the initial
search. Boolean operating search strings were employed to
ensure that the most suitable papers were retrieved. Table 1
outlines the search strategy that was implemented for lit-
erature retrieval.
2.2. Eligibility Criteria. Applying inclusion and exclusion
parameters to the literature search process facilitated the
Vascular
remodelling
Angiogenesis
Migration
Production/
degradation of
ECM
Angionecrosis
Ischaemia-induced haemodynamic stress
Release of haemodynamic stimuli, growth factors, and vasoactive substances
Stabilisation of
haemodynamics
Elimination of dead cells by
surrounding macrophages Release of growth factors
Inhibition of neural growth
Structural rearrangement of vasculature
Figure 2: Biological process of vascular remodelling. Angiogenesis, migration of vascular cells, production and degradation of the ECM, and
angionecrosis constitute the major pathological hallmarks of vascular remodelling. ECM, extracellular matrix.
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retrieval of the most appropriate papers. Search results were
restricted to papers published in English within the last 10
years (i.e., between 2008 and 2018, inclusive), as the translation
of papers published in non-English languages may have dis-
torted the understanding of the research. In vivo studies of
small animals were included, and several papers discussing the
same imaging technology were not disregarded, as these would
only strengthen any common conclusions formed from these
studies. Only primary research papers were included in the
ﬁnal analysis; other secondary or tertiary publications such as
reviews, books, conference proceedings, presentations, and
abstracts were only referred to for background or follow-up
information and are cited accordingly in the discussion.
2.3. Quality Appraisal. *e Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guide-
lines were followed to ensure that the most appropriate
research papers were included in this review. *e PRISMA
guidelines were established by David Moher and colleagues
to conceptually represent the progressions within the ﬁeld of
systematic literature reviews. *e papers that were retrieved
from the search process following this model were sys-
tematically categorised according to their signiﬁcance in
helping to answer the overall aim of this research [13].
2.4. Data Collection and Analysis. Each of the retrieved
papers from the literature search focussed on one or more
imaging techniques. *e next step involved assessing these
imaging techniques based on relevant parameters to evaluate
whether they could be implemented to observe neuro-
vascular remodelling following ischaemic injury. Accord-
ingly, the following details were extracted from each of the
retrieved papers, where available: imaging technique, pur-
pose of the study, animal model used, spatial resolution or
ﬁeld of view, duration of scanning, contrast agent or mo-
lecular probe utilised, safety considerations for imple-
mentation in humans, and considerations for modality-
speciﬁc image interpretation.
Although an eﬀective imaging technique may oﬀer ex-
cellent image resolution with minimal patient invasiveness,
it may not be considered optimal for the purposes of clinical
translation if the acquired data are exceedingly diﬃcult and
time-consuming to acquire and even process. By analysing
and discussing comparisons between diﬀerent technical
characteristics and across a variety of imaging techniques,
appropriate strategies to employ for postischaemic imaging
can then be determined.
3. Results
*e PRISMAmodel, as outlined in the previous section, was
used to select the literature for this review. *e articles’
ﬁltering process is presented in Figure 3.
*e results of the literature search essentially revealed a
number of imaging parameters for each imaging technique
that may be relevant for the imaging of neural vasculature,
particularly following ischaemic trauma. *ese relevant
parameters, along with a brief overview of the imaging
techniques, are presented in Table 2.
*e distribution of the selected publications per year is
presented in Figure 4. *ere evidently appears to have been
peaks of relevant research published in 2009, 2014–2015, and
2017 in relation to the search queries for this review, which
may indicate a marginally increasing trend in studies of
postischaemic neurovascular remodelling in the last 5 years.
4. Discussion
4.1. Rationale. Neurovascular remodelling is a process that
establishes an ideal biological environment for neurological
healing. Proceeding after an ischaemic injury, neurovascular
remodelling acts to restore the haemodynamic stability of the
brain, inhibit neural degeneration, eliminate any dead cells by
surrounding macrophages, and facilitate the release of growth
factors. Many signalling compounds and chemokines are
involved in cell–cell interactions to facilitate attempts to
salvage surviving neural tissue and reorganise the vasculature
following ischaemic injury [17, 49]. A better understanding of
these remodelling processes can enhance clinical diagnostics
and restorative therapy options; thus, improved visualisation
of this vascular reorganisation within the brain is beneﬁcial.
*ese biological pathways involve some of the samemolecules
that have already been used to inform the development of
probes and tracers for the clinical study, such as the glucose
analogue [18F]FDG. Nonetheless, there remains a knowledge
gap about the biological processes of neurovascular remod-
elling that can be answered by imaging the regions in which
Table 1: Literature search strategy.
Initial search
terminology
Synonyms and
related terminology
Truncations
and wildcards
ischaemic
ischaemia
low blood
low blood ﬂow
low oxygen
hypoxia
stroke
isch?emia
ischaemi∗
ischemi∗
hypoxi∗
neuro
brain
cerebral
neurological
neuro∗
cerebro∗
vascular
vasogenic
blood vessels
arteries
vascular∗
arteri∗
remodelling rearrangementreorganisation
remodel?ing
remodel∗
reorgani?ation
imaging
scanning
observing
assessing
measuring
monitoring
detecting
imag∗
scan∗
observ∗
assess∗
measur∗
monitor∗
detect∗
*e initial search terminology stemmed from the wording of the overall aim
of the review. *e inclusion of alternative terminology and truncation and
wildcard operators helped to uncover a wider range of papers from the
databases. Some searches were also conducted with the exclusion of
“remodelling” to assess whether imaging methods could potentially be
implemented for this purpose.
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Full-text papers included in analysis (n = 35)
Abstracts and titles screened (n = 139)
Papers identified 
through initial 
database search 
(n = 109)
Papers identified 
from citation lists and 
repeat searches 
(n = 30)
Papers excluded 
based on eligibility 
criteria (n = 104)
Figure 3: *e Preferred Reporting Items for Systematic Reviews and Meta-Analyses model, as implemented for this systematic review. A
ﬁnal total of 35 papers were included in the literature analysis (adapted from [13]).
Table 2: Literature search results and extracted data.
Reference Method and application(models)
Imaging
parameters
Contrast agent or
molecular probe
Safety
considerations for
clinical translation
Applications
Bosomtwi
et al. [14]
MRI to observe poststroke
vascular changes (rats) FOV: 32mm Feridex Noninvasive
Tissues can be
monitored long term
through stages of
angiogenesis enabling
evaluation of vascular
remodelling
Bosomtwi
et al. [15]
MRI in combination with
LSCM to visualise postischaemic
changes in vasculature (rats)
FOV: 32mm MIONs
Noninvasive;
high doses of
intravascular agent
are required
LSCM can be used to
validate MRI data;
poststroke vascular
remodelling can be
three-dimensionally
quantiﬁed
Brunner
et al. [16]
fUS to measure postischaemic
cerebral blood volume (rats)
Resolution: 100 μm,
FOV: 12.8× 9mm2,
duration: approx.
3min
None
No contrast agent
injections are
required
Stroke longitudinally
studied across all stages;
can image whilst in
motion, as the probe is
implanted on the head
Cai et al.
[17]
PET to observe VEGFR
expression in poststroke
angiogenesis (rats)
—
64Cu-DOTA-
VEGF121
—
Some cellular VEGFRs
may be visualised,
resulting in the
potential to observe
poststroke
reorganisation and
plasticity
Deddens
et al. [18]
MRI to detect vascular
remodelling after cerebral
ischaemia (mice)
FOV:
1× 1.2× 2 cm3
PECAM-1-
targetted FeOx
microparticles
—
PECAM-1 can be used
to assess poststroke
vascular remodelling
Ding et al.
[19]
MRI to visualise poststroke
cerebral angiogenesis (rats)
FOV:
32× 32×16mm3 Gd-DTPA Noninvasive
Detect angiogenesis
and determine the
temporal proﬁle of
angiogenic processes
Errico et al.
[20]
Ultrafast US localisation
microscopy to visualise
neurovasculature and quantify
haemodynamic characteristics
(rats)
Resolution:
12.5× 2.5×1 μm3
Inert
perﬂuorocarbon-
ﬁlled microbubbles
Microbubbles are
clinically approved
contrast agents
Even slight
haemodynamic changes
in neurovasculature can
be monitored; the
resolution can be
enhanced by localising
microbubbles directly
from radiofrequency
data; motion correction
algorithms needed
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Table 2: Continued.
Reference Method and application(models)
Imaging
parameters
Contrast agent or
molecular probe
Safety
considerations for
clinical translation
Applications
Figueiredo
et al. [21]
CTA
To observe cerebral
vascular anatomy
and blood ﬂow
(mice)
Resolution:
163 μm3, duration:
20–40 s
Iomeprol
Injection of
contrast agent is
required
Can detect changes in
the diameter of
vasculature
MRA
Resolution:
31× 31× 93 μm3,
FOV: 12×16mm2,
duration: 58min
None No ionisingradiation —
Digital
subtraction
angiography
Resolution:
14×14 μm2,
duration: 3 s
Iomeprol
Low injection
volume and dose of
radiation, although
much more
invasive than CTA
and MRA
Can detect changes in
intracerebral blood
ﬂow
Gramer
et al. [22]
PET, LSI, and RGB reﬂectometry
to measure CBF, blood
oxygenation, and glucose
metabolism (rats)
Resolution (PET):
1.3mm (FWHM),
FOV: 12× 7mm2
[18F]FDG
*in-skull
preparation is
required
Can be used to quantify
metabolic activity of
neurovasculature in
real time making it
suitable for studying
pathological
conditions. Partial
volume is an issue
Horton
et al. [23]
Triphoton ﬂuorescence
microscopy to visualise
hippocampal vasculature (mice)
Resolution: 4.4 μm
(axial, FWHM)
Dextran-coupled
Texas Red dye —
Overcomes the
limitations of two-
photon microscopy,
such as signal-to-
background ratio of
excitation in scattering
tissues and lack of
ﬂuorescent labels that
can be used
Howles
et al. [24]
Contrast-enhanced MRA to
visualise neurovasculature (mice)
Resolution:
52× 52×100 μm3,
FOV:
20× 20× 8mm3,
duration: approx.
12min
SC-Gd liposomal
nanoparticles —
SC-Gd allows for high
contrast-to-noise ratio;
useful to visualise very
small vascular
structures
Hu et al.
[25]
Optical-resolution PAM to study
micro-haemodynamic activities
(rodents)
Resolution:
5×15 μm2 — Noninvasive
Can help quantify
changes in metabolic
parameters
Huang et al.
[26]
MRI to assess vascular reactivity
and functionality during
postischaemic proangiogenic
vascular remodelling (rats)
FOV:
2.56× 2.56 cm2 — —
Anaesthesia protocols
must be optimised to
minimise physiological
disturbance
Jimenez-
Xarrie et al.
[27]
MRI to assess postischaemic
cerebrovascular damage
FOV: 32× 32mm,
duration: 9min 17 s None
Isoﬂurane
anaesthesia can
aﬀect stroke
outcomes and
evaluation of
vascular changes
Long-term vascular
consequences of
ischaemia with
coincident
hypertension
can be studied
Kolodziej
et al. [28] SPECT to study CBF (mice)
Resolution: 0.7mm
(FWHM), FOV:
20.9mm (axial),
duration: approx.
2 h
99mTc-HMPAO
99mTc-HMPAO is
lipophilic and is
quickly cleared
from the plasma
Uses pinhole imaging
for higher resolution
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Table 2: Continued.
Reference Method and application(models)
Imaging
parameters
Contrast agent or
molecular probe
Safety
considerations for
clinical translation
Applications
Lake et al.
[29]
MRI to assess poststroke brain
morphology and vascular
function (rats)
Resolution:
0.1× 0.1mm2,
duration: <12min —
Propofol
anaesthesia induces
20–60% regional
vasoconstriction,
which may
inﬂuence vascular
studies
Functional MRI can be
used tomeasure resting
blood ﬂow and
cerebrovascular
reactivity; structural
MRI may have limited
sensitivity to detect
subtle changes in tissue
morphology
Lecoq et al.
[30]
Two-photon phosphorescence
lifetime microscopy to measure
the partial pressure of oxygen and
blood ﬂow (mice)
Resolution: <1 μm
(lateral)
Phosphorescent
nanoprobe PtP-
C343
Minimally invasive;
the probe is neither
toxic nor
phototoxic
Oxygen gradients in
microvascular
networks can be
distinguished; this is
particularly useful for
postischaemia imaging
Letourneur
et al. [31]
Two-photon laser scanning
microscopy to longitudinally
image vascular development
(mice)
Duration: 50–150 s
Fluorescein-
conjugated dextran
and Texas Red-
dextran
Requires thinning
of the skull; head
must be
immobilised
Can longitudinally
image the same areas
over many days; can
measure ﬂow dynamics
over time in relation to
changes in vessel
diameter
Li et al. [32] LSI to study neurovasculature(rats)
Resolution:
6.7× 6.7 μm2 None
Requires thinning
of the skull
Diﬀerent circulatory
dynamics can be
observed at diﬀerent
spatial locations
Liao et al.
[33]
Functional PAM to study
functional changes in total
haemoglobin concentration,
cerebral blood volume, and
haemoglobin O2 saturation in
cerebral blood vessels (rats)
Resolution:
36× 65 μm2 None —
Can be complemented
with other imaging
modalities for label-
free visualisation of
neurovasculature
Lin et al.
[34]
3D ΔR2-based microscopy of
MRA to visualise poststroke
changes in neurovasculature
(rats)
Resolution:
54× 54× 72 μm3,
FOV:
2.8× 2.8×1.4 cm3,
duration: 76min
MIONs
Greater magnetic
ﬁelds may be
needed to visualise
smaller vessels
Can simultaneously
visualise microvascular
morphology and reveal
physiological
properties of
microvascular cerebral
blood volume
Luckl et al.
[35]
LSI and imaging of intrinsic
signals to study CBF dynamics
during ischaemia (rats)
Resolution: 140 μm
every 2 s, FOV:
5× 5mm2
Erythrosin B dye
Requires thinning
of the skull for
better observation
Vascular changes in
metabolism can be
quantiﬁed
Miao et al.
[36] LSI to study angiogenesis (rats) FOV: 4.7× 4.7mm
2 None Requires thinningof the skull
CBF under various
pathological states can
be analysed, and smaller
vessels can be enhanced;
results can be aﬀected
by motion artefacts
Nagaraja
et al. [37]
MRI to visualise poststroke
changes in the BBB (rats) FOV: 32mm
Gd-DTPA and Gd-
DTPA linked to
bovine serum
albumin and Evans
blue dye
Noninvasive
Diﬀerent
measurements are
obtained with diﬀerent
contrast agents;
quantifying BBB
permeability can help in
understanding the
progression of
ischaemic injury
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Table 2: Continued.
Reference Method and application(models)
Imaging
parameters
Contrast agent or
molecular probe
Safety
considerations for
clinical translation
Applications
Sakadzˇic´
et al. [38]
Two-photon phosphorescence
lifetime microscopy to measure
partial pressure of oxygen in
cortical microvasculature under
hypoxic conditions (rats, mice)
—
Phosphorescent
nanoprobe PtP-
C343
Minimally invasive
with low doses of
the probe required;
no detected leakage
of the probe into
interstitial spaces
*e partial pressure of
oxygen can be
simultaneously
assessed at various
positions and depths,
making it more feasible
to functionally study
transient changes in
oxygen levels
Schambach
et al. [39]
Volume-CTA to visualise cerebral
vessels (mice) Duration: 40 s
Iodinated contrast
agent
Large dose of
contrast agent is
required
Changes in vessel
diameter can be
monitored
Schroeter
et al. [40] PET
To observe
postischaemic
vascular changes
(rats)
Duration: up to
60min
[18F]FDG and [11C]
PK11195 Noninvasive
Characterise
neuroinﬂammation and
metabolic disruptions
repeatedly over time.
MRI FOV: 3.0 cm — Noninvasive Can help localise areasof infarction
Seo et al.
[41]
Contrast-enhanced μCT to
visualise poststroke changes in
cerebral vasculature (rats)
Duration: approx.
2min Iopromide
High doses of
iodinated contrast
agent are needed
Images are subject to
blurring due to
physiological motion
Stein et al.
[42]
PAM to study blood oxygenation
dynamics of hypoxic cerebral
vasculature (mice)
Resolution:
70× 54 μm2
None; monitors
“endogenous”
haemodynamics
Noninvasive
Single blood vessels can
be noninvasively
assessed in real time
Struys et al.
[43]
PET
To characterise
acute and long-
term vascular and
metabolic eﬀects of
unilateral common
carotid artery
occlusion (mice)
Resolution:
1.35mm
(transaxial,
FWHM), duration:
10min
[15O]H2O and [18F]
FDG
—
Can be used to monitor
short-term/long-term
perfusion and vascular
remodelling in
ischaemic stroke
models
MRI
Resolution:
98× 98 μm2, FOV:
2.5× 2.5 cm2
—
Tsukada
et al. [44]
PET to study postischaemic
changes (monkeys) Duration: 91min
[18F]ﬂurpiridaz and
[18F]BCPP-EF
Surgical procedures
are invasive and
require anaesthesia
Study metabolic
properties and
distinguish
inﬂammatory
processes
Yanev et al.
[45]
Steady-state contrast-enhanced
MRI to assess the changes in
cerebral blood volume and
microvascular density after
transient stroke (rats)
FOV: 30× 30mm2,
duration: approx.
135min
Ultrasmall iron
oxide particles —
Changes in cerebral
blood volume and
microvascular density
can be observed at least
3 months after stroke;
only perfused (and
therefore functional)
vessels can be detected
Yoon et al.
[46]
Multiphoton luminescence to
visualise morphological changes
in cortical vasculature over time
(mice)
— PEG-GNPs
PEG-GNPs are
highly
biocompatible
Long circulation time
of PEG-GNPs enables
vascular imaging for
several hours, making
them suitable to
observe remodelling
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the neurovascular changes occur. Consequently, this review
purports itself to identify current imaging technologies being
used in neurovascular research to observe postischaemic
neurovascular remodelling in small animals. Various tech-
niques were revealed in the published literature and evaluated
against a set of properties and common measures in image
analysis that were deemed relevant for vascular imaging in the
brain. *e imaging techniques have been categorised to help
identify when certain modalities may be more appropriate for
the given purpose. *is review provides guidance in the
identiﬁcation of imaging modalities for diﬀerent translational
applications.
4.2. Animal Models of Ischaemia. Small animals play a
valuable role in elucidating the mechanisms underlying is-
chaemia. *e use of small animal models allows for greater
control and reproducibility to precisely evaluate ischaemic
pathophysiology, compared to human cases that involve
heterogeneous manifestations and causal factors. Invasive
techniques can also be implemented in small animals for direct
access to the brain vasculature, although they are undesirable
in the context of clinical translatability. Furthermore, animal
models allow for the study of immediate postischaemic
changes, providing insights into early-stage mechanisms [50].
Some common rodent models of stroke include the (a) middle
cerebral artery (MCA) occlusion (MCAo) model, which in-
volves temporarily or permanently disrupting blood ﬂow in
the MCA and associated vascular branches that are pre-
dominantly aﬀected in human stroke; (b) craniotomy model,
which involves craniectomy and removal of a section of dura
mater to access the MCA; (c) embolic stroke model, which
involves the application of micro/macrospheres or clots to
induce ischaemic lesions; (d) endothelin-1 (ET-1) model,
which involves the application of ET-1 to a neural region of
interest (often the MCA) to act as a vasoconstrictor and thus
induce ischaemia; and (e) photothrombosis model, which
involves targeted photo-oxidation to generate precise
ischaemic lesions [50–54]. *e most commonly reported is-
chaemiamodels in the papers identiﬁed in this reviewwere the
embolic stroke, MCAo, and craniotomy models (Figure 5).
Diﬀerent stroke models have diﬀerent advantages and may
provide information on diﬀerent aspects of postischaemic
changes; therefore, it is useful to consider the type of in-
formation that is desired when designing an imaging study.
4.3. Fundamentals. Neurovascular remodelling undergoes
several phases in its process of ultimately establishing fully
functional vasculature. To better understand postischaemic
Table 2: Continued.
Reference Method and application(models)
Imaging
parameters
Contrast agent or
molecular probe
Safety
considerations for
clinical translation
Applications
Yu et al.
[47]
Spectral Doppler OCT to
quantitatively assess dynamic
blood ﬂow before and after stroke
(mice)
Duration: approx.
20min Rose bengal —
Mimics ischaemic
conditions by reducing
CBF in
microvasculature; the
pulsatility of CBF is
quantiﬁed; changes in
heart rate due to
anaesthesia wearing oﬀ
and being
readministered must be
considered
Zhang et al.
[48]
SR-PCI to visualise neural
microvasculature (rats)
Resolution:<10 μm, FOV:
approx. 3mm
None High doses ofionising radiation
Vascular architecture
and volume can be
visualised and
quantiﬁed; FOV is
limited
External sources were not consulted to ﬁll in missing details at this stage in the research. Abbreviations: FOV, ﬁeld of view; MRI, magnetic resonance imaging;
LSCM, laser scanning confocal microscopy; MION, monocrystalline iron oxide nanoparticle; fUS, functional ultrasound; PET, positron emission tomography;
VEGFR, vascular endothelial growth factor receptor; PECAM, platelet endothelial cell adhesion molecule; Gd-DTPA, gadolinium-diethylenetriaminepentaacetate;
US, ultrasound; CTA, computed tomography-angiography;MRA,magnetic resonance angiography; LSI, laser speckle imaging; RGB, red-green-blue; CBF, cerebral
blood ﬂow; FWHM, full width at half maximum; [18F]FDG, [18F]ﬂuorodeoxyglucose; SC-Gd, surface-conjugated gadolinium; PAM, photoacoustic microscopy;
SPECT, single-photon emission computed tomography; 99mTc-HMPAO, 99mTc-hexamethylpropyleneamineoxime; BBB, blood-brain barrier; μCT,microcomputed
tomography; PEG-GNP, polyethylene glycosylated gold nanoparticle; OCT, optical coherence tomography; SR-PCI, synchrotron radiation phase contrast imaging.
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changes, studying neurovascular remodelling in its indi-
vidual stages is ideal. *e individual characteristics of these
phases can be measured to provide a better understanding of
the postischaemic reorganisation that occurs. Firstly, a
cellular cascade instigated by endothelial cells causes
heightened permeability of vessels due to the deterioration
of key vascular junctions. *is, in turn, enables the ex-
travasation of plasma proteins, which helps construct a
framework for the development of new vessels. *ereafter,
the growth of new vasculature leads to ﬂuctuations in
haemodynamic properties, such as cerebral blood ﬂow and
volume, as well as in vessel density, whilst the vascular
network continues to develop. *e remapping of the vas-
cular network in response to ischaemia is an important
aspect of appreciating neurovascular outcomes [55, 56].
*erefore, it might be of considerable value to utilise
small nanometre-scale intravascular contrast agents that
could trace this extravasation to signal the generation of new
vasculature. Agents of diﬀerent sizes could help detect
diﬀerent levels of permeability in diﬀerent areas at diﬀerent
intervals, whilst enhanced opaciﬁcation could ideally be
achieved by utilising a higher density contrast. Ideally, an
imaging approach would enable the dynamic visualisation of
both large and small vessels as postischaemic angiogenesis
proceeds for a more complete picture of the vascular mi-
croanatomy, although studying microvascular changes
might oﬀer signiﬁcant information about the earliest pos-
tischaemic processes. Hence, to distinguish individual ves-
sels, the image resolution should complement the range of
vessel diameters. An imaging resolution of at least 0.5mm
would confer the greatest beneﬁt if the biological tracer
being utilised is nonspeciﬁc to the vasculature, since cerebral
arteries are larger in diameter than this, although a more
precise range may be necessary to observe the remodelling of
microvessels [57–59]. Nevertheless, neurovascular remod-
elling is not a one-oﬀ event; thus, the capacity to obtain
repeated measurements over time (i.e., longitudinal imag-
ing) is also desirable in an ideal imaging approach, thereby
circumventing the need for more invasive methods. By
visualising early processes, studies can infer postischaemic
remodelling changes from an earlier time point. *is would
be valuable in a twofold manner. Firstly, experiments could
retain a larger sample size, given the survival durations after
ischaemia. Secondly, studying earlier fundamental processes
using imaging would allow for better correlations with later
outcomes in studies of neurovascular outcomes.
4.4. General Overview of ImagingModalities. A wide array of
imaging techniques have been implemented within the last
10 years in preclinical small animal models speciﬁcally for in
vivo visualisation of vascular changes following ischaemic
injury. Magnetic resonance imaging (MRI) and positron
emission tomography (PET) remain the predominant mo-
dalities of choice to study postischaemic neurovascular
changes, despite the advent of numerous other modalities
being implemented over the last 10 years (Figure 5).
According to a survey (n� 173) conducted amongst UK and
non-UK university researchers and UK National Health
Service personnel, MRI is amongst the topmost researched
areas [60].
Well-established modalities such as computed tomog-
raphy (CT), MRI, and PET were expectedly found in the
literature; in addition, several other methods have been
developed and introduced relatively recently. *ese include
ultrafast ultrasound localisation microscopy (uULM), which
incorporates the use of inert gas microbubbles for precise
visualisation of cortical vessel branching; synchrotron ra-
diation phase contrast imaging (SR-PCI), which does not
require the administration of a contrast agent, but it involves
high doses of ionising radiation; the use of gold-coated
nanoparticles in multiphoton luminescence to allow for
repeated imaging over time (Figure 6); and functional ul-
trasound (fUS), which can be implemented in freely moving
models without the use of contrast agents [16, 20, 46, 48].
Each new imaging modality improves on singular aspects of
imaging vascular disease and may likely serve as an adjunct
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Figure 5: Frequency distribution of imaging modalities amongst
papers retrieved through the literature search, with further dis-
tinction of the ischaemia induction models implemented. Magnetic
resonance imaging and positron emission tomography were the
most common techniques employed for in vivo preclinical studies
of postischaemic neurovasculature. Other modalities included one
instance each of multiphoton luminescence, optical coherence
tomography, ultrafast ultrasound localisation microscopy, syn-
chrotron radiation phase contrast imaging, digital subtraction
angiography, microcomputed tomography, red-green-blue re-
ﬂectometry, single-photon emission computed tomography,
functional ultrasound, laser scanning confocal microscopy, three-
photon ﬂuorescence microscopy, and two-photon laser scanning
microscopy. *e MCAo/CCAo model was used most commonly
across all the imaging modalities. Open-skull intervention included
craniotomy, thinning of the skull, and electrode or optic ﬁbre
implantation. MRI, magnetic resonance imaging; PET, positron
emission tomography; LSI, laser speckle imaging; MRA, magnetic
resonance angiography; PAM, photoacoustic microscopy; CTA,
computed tomography angiography; 2P-PLM, two-photon phos-
phorescence lifetime microscopy; MCAo, middle cerebral artery
occlusion; CCAo, common carotid artery occlusion.
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to existing clinical imaging modalities. Given the general
accessibility of PET and MRI and their preexisting use in
patients, these well-established techniques are likely to
persist and receive the bulk of the relevant research focus.
Nonetheless, much like PET/CT being a widely available
hybrid system, continued study of neurovascular remodel-
ling is likely to rely on more than one technique to develop
our understanding and help ﬁne-tune the output data from
these large-scale techniques. *ese novel methods show
promise for neurovascular imaging, and it would be of
interest to follow any future work involving these methods.
4.5. Imaging Speciﬁcations Representing Limitations to
Overcome. Multiphoton microscopy is a ﬂuorescence
technique that eﬀectively merges laser scanning microscopy
with pulsatile multiphoton excitation to image tissues that
have been labelled with ﬂuorophores [61].*is approach has
been actively employed to investigate the mechanisms of
neurovascular reorganisation following ischaemic injury
[62]. Despite the high spatial resolution from targeted im-
aging, this technique suﬀers from slow imaging times,
limited ﬁelds of view, and depth of tissue penetration. For
example, live imaging in small rodents requires a cranial
window—an opening in the skull for optical access to the
parenchyma—to be created in the model being tested. *is
functionally limits the ﬁeld of view available. In rats, a large
cranial window (e.g., 4 × 6mm2 in size) is usually created,
involving removal of the overlying bone and resection of
the dura mater, to enable the insertion of devices, such as
cannulae and electrodes. *is step is complicated by the
need to reseal the window to reestablish intracranial
pressure and reduce motion artefacts [63]. Mice, on the
contrary, are a good alternative because cranial window
generation is less invasive than that in rats; the thin skull of
mice can remain intact and only requires thinning for a
resulting cranial window (e.g., 2× 2mm2 in size), which
produces limited disruptions in intracranial pressure and
decreased inﬂammation [64]. *erefore, animal choice
forms a key part of designing such imaging experiments.
PET and single-photon emission computed tomography
(SPECT) are molecular imaging techniques that track bi-
ological target-speciﬁc changes in function with high sen-
sitivity. Nonetheless, their relatively poor resolution (around
0.8mm for PET and 0.3mm for SPECT) prevents ana-
tomically speciﬁc imaging and presents as a limiting factor,
whichmay also augment partial volume eﬀects and inﬂuence
the measurement of vascular parameters. Partial volume
eﬀects are a direct response to multiple tissue types present
within a single voxel, hence generating image blurring.
Partial volume eﬀects refer to the diﬀerence between actual
and obtained image intensity values and typically occur
when more than one type of tissue is contained within
individual voxels, ultimately inﬂuencing the quantiﬁcation
of key parameters. Larger voxels have a greater probability
of containing various tissue types in comparison to smaller
voxels. *e consequential blurring eﬀects are essentially the
result of the interplay between low spatial resolution and
limited tissue sampling. Methods to correct for partial
volume eﬀects in PET imaging represent an active ﬁeld of
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Figure 6: In vivo multiphoton luminescence imaging using PEG-GNPs of cerebral vasculature in murine stroke models. (a) Experimental
timeline, prior to which an open-skull cranial window was generated in a live mouse. Photothrombosis was induced within the vessels to
generate the mouse model. (b) Multiphoton luminescence images of neurovasculature before and after induction of photothrombotic stroke
with 5 and 40 nm sized PEG-GNPs. Scale bar, 100 µm. (c) Relative luminescence of extravascular tissues following photothrombosis.∗∗∗P< 0.001, one-tailed t-test, n� 3; values are mean with standard deviation. PEG-GNP, polyethylene glycosylated gold nanoparticle
(republished with permission from the Royal Society of Chemistry [46]; permission conveyed through Copyright Clearance Center, Inc).
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research [65–67]. *e biggest advantage of using these nu-
clear medicine techniques despite the poor anatomical deﬁ-
nition is that dynamic, real-time imaging becomes possible.
Dynamic imaging oﬀers considerable diagnostic information
that may not be accessible from static imaging by overcoming
the bias presumed by static imaging, in which a single time
frame is selected to reﬂect the overall tracer metabolism
without correcting for variabilities in distribution and activity
[68]. *is advantage of dynamic imaging is important for
neurovascular studies when studying absolute blood ﬂow
dynamics and the remodelling process.
If anatomical detail is required, MRI provides a com-
plement of both real-time imaging and high spatial reso-
lution without the use of ionising radiation [3]. Access to
MRI systems incorporating ultrahigh magnetic ﬁelds
(i.e., greater than 9.4 T) can allow for the acquisition of
images with higher spatial resolution [69]. *is enhance-
ment of resolution, however, comes at the cost of increased
scan durations. With lengthier scans, the probability of
involuntary movements (e.g., cyclic respiration) increases,
thus resulting in lower-quality images [57]. An apparently
missing imaging technique from the preclinical imaging
investigations is functional MRI (fMRI). In patients, these
limitations in resolution and real-time imaging have been
increasingly overcome by fMRI. Even if this is perhaps one
of the most successful imaging modalities in the clinic, its
fundamental principle of operation and practical aspects
make it largely incompatible for standard imaging of small
animals [70].
In general, particularly high-resolution parameters for
vascular imaging may be achieved by the newer uULM
(Figure 7) and SR-PCI techniques (<10 µm), but also by
SPECT (<1mm), photon excitation microscopy (<1 µm),
and angiography (<20 µm); however, the applications of
these may come at the cost of longer scanning durations, the
use of contrast agents, cranial window generation, or high
ionising radiation doses [20, 21, 28, 30, 48, 62]. On the
contrary, when a technique is minimally invasive to the
subject, the resolution is compromised, as noted with MRI
(0.1mm, <30mm) and functional photoacoustic microscopy
(fPAM; <30 µm) [14, 15, 19, 33, 37, 40, 42, 71, 72]. Researchers
have many imaging modalities available to them; however, it
is important to understand the limitations of each technology
and design experiments based on the limitations of the
modalities.
4.6. Contrast Agents and Molecular Probes. Imaging with
molecular probes is useful for studying active biological
processes at cellular and subcellular levels. Most molecular
probes are radionuclide tracers and are used because of their
ability to emit radiation from within the body including cells
in which these tracers are taken up. As a result, radionuclide
imaging oﬀers both qualitative and quantitative data on
dynamic biological processes [17, 73]. Meanwhile, contrast
agents also emit signals that can enable the collection of
qualitative data on the vascular architecture, although there
have been discussions regarding their potential side eﬀects
[74, 75].
PET is well established as a valuable method to visualise
the interplay between changes in cerebral blood ﬂow and
the metabolic needs of ischaemic tissues. *e eﬀectiveness
of PET in understanding diﬀerent aspects of postischaemic
vascular processes depends largely on the types of tracers
utilised. For example, [15O]-radiolabelled tracers oﬀer
the ability to quantify a number of haemodynamic char-
acteristics, such as cerebral blood ﬂow, cerebral blood
volume, cerebral metabolic rate of oxygen, oxygen ex-
traction, and energy metabolism [3]. *e most common
tracer used in PET imaging is [18F]FDG, although other
tracers such as [18F]MISO, [18F]BCPP-EF, and [11C]
PK11195 have been utilised as well for diﬀerent applica-
tions [22, 40, 44, 76].
Diﬀerent molecular factors, such as vascular endothelial
growth factor (VEGF), trigger angiogenesis as a component
of vascular remodelling, and these processes are regulated by
the interplay between components of extracellular matrices
and adhesion molecules. VEGF, associated adhesion mol-
ecules (e.g., integrins), and microvessel density can thus be
useful targets to detect and visualise angiogenesis using
probes that are speciﬁc to radionuclide imaging techniques
[17, 73, 77]. *e use of [15O]H2O as a PET tracer was also
noted. Although blood oxygen level-dependent fMRI con-
fers better spatial and temporal resolution and reduced
radiation exposure, [15O]H2O PET beneﬁts include quan-
titative data output and the capacity for longitudinal imaging
[78]. Accordingly, few [15O]H2O PET studies have been
conducted to evaluate cerebral blood ﬂow and other hae-
modynamics in small animals primarily due to the short
half-life of 15O and its potentially high-energy emitted
positron, which render the PET images noisier and of lower
resolution. Nevertheless, the development of [15O]H2O-
based imaging in small animals is an increasing focus of
recent research, and the aforementioned challenges may be
technically addressed in the near future (more information is
available on the website of the project Small Animal Fast
MRI Insert at https://saﬁr.ethz.ch) [43, 79–82].
Despite the high resolution of MRI, it generally does not
require intravenous contrast agent injections; however, MRI
may be enhanced by eﬀective contrast agents for visual-
isation or quantitative analysis, and this can be facilitated by
monocrystalline iron oxide nanoparticles (MIONs). MIONs
are useful contrast agents because they are relatively cost-
eﬀective to produce, nontoxic, biocompatible, and both
chemically and physically stable [83]. Although they are able
to depict the vascular architecture clearly, it is important to
note that utilising MIONs or any intravascular MRI contrast
agents may cause diﬃculties in evaluating vessels with large
diameters due to the contrast agent particles reducing the
baseline intravascular signals from larger vessels. *is
suggests that there may exist an upper threshold in studying
vascular remodelling using contrast-enhanced MRI and that
only small-vessel changes may reliably be observed. *is
might be an important aspect to consider when assessing
vascular remodelling that includes larger vessel sizes and
densities [15, 34, 57, 84].
CT methods, such as micro-CT (µCT) and CT angiog-
raphy, oﬀer detailed images of the neurovascular
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architecture. *eir strengths are reﬂected in their ability to
rapidly generate high-resolution images at relatively low
costs [9, 85]. CT angiography involves the administration of
an intravenous contrast agent to visualise the vasculature on
thin-section images in any plane. Moreover, these detailed
images can be obtained in short time frames of approxi-
mately less than a minute [21, 39]. Whilst CT does not oﬀer
the same degree of soft-tissue resolution as MRI, CT scans
are not contraindicated when metal is present. *is is
uniquely beneﬁcial because animals with implants or devices
can still be imaged. For qualitative data on structural changes
in the neurovasculature, CTmay be a more practical choice
of imaging modality, which may require supplementation by
other imaging modalities for quantiﬁcation.
(a)
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Figure 7: (a) Coronal-view image of uULM performed through a thinned-skull window, conferring a resolution of 10× 8 µm2. (b) In-plane
velocity map of some vessels from (a). (c) Coronal-view image of uULM performed through an intact skull, conferring a resolution of
12.5×1 µm2. (d) In-plane velocity map of some vessels from (c). uULM, ultrafast ultrasound localisation microscopy [20] (reprinted with
permission from Copyright Clearance Center, Inc. [20]).
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*is systematic literature review also revealed a number
of techniques that do not require the administration of
contrast agents or tracer molecules; these include fUS,
photoacoustic microscopy (PAM), fPAM, laser speckle
imaging (LSI), and SR-PCI [16, 32, 33, 36, 42, 48]. Evidently,
evading the need for intravenous injections would render
these techniques as attractive and ideal for translation to
clinical practice. LSI has already been implemented to assess
systemic microvascular function in patients with and
without cardiovascular disease [86]. Meanwhile, PAM has
been used previously to evaluate vascular proﬁles and ox-
ygen saturation in patients with complex regional pain
syndrome, as well as to visualise the microvasculature and
changes in vascular networks in patients with and without
acral melanoma [87, 88].
4.7. Safety Considerations in Small Animals. Depending on
the type of study being designed, there are diﬀerent safety
issues to consider. Some optical imaging modalities involve
directly exposing cerebral tissue via thinning of the skull or
creation of a cerebral window, after which intravascular
labels can be monitored as close to the surface as possible
[61]. Because of the invasiveness required, in addition to
oﬀering comparatively small ﬁelds of view due to minimal
penetration of tissue, they are commonly employed in small
animal preclinical studies [63, 69]. Alternatively, other
optical approaches such as ﬂuorescence microscopy oﬀer the
ability for repeated imaging longitudinally in the same
animals, which circumvents two major problems: (1)
needing to sacriﬁce animals after critical time intervals in a
study and (2) using diﬀerent cohorts of animals for diﬀerent
time points [89]. In this way, noninvasive imaging tech-
niques may allow for longer experiments over a span of
several days, weeks, or months with minimal interruption to
the animals whilst monitoring dynamic processes like
neurovascular remodelling after ischaemic stroke.
Dose-equivalent radiation is another concern. *e
performance of µCT is inﬂuenced by the X-ray source
utilised. In preclinical applications, µCT involves signiﬁ-
cantly lower photon output than that used in clinical CT
scanners. Long (e.g., around 50min) average scan durations
may thus be required for preclinical µCT to achieve com-
parable noise levels to those in clinical CT [90]. Maintaining
recovery anaesthesia, restricting movements, and mini-
mising ionising radiation doses over longer periods then
become major procedural concerns [39]. *e eﬀects of large
doses of radiation on such small animals must also be
considered. However, a recent study that evaluated X-ray
doses and their corresponding biological eﬀects in experi-
mental animals that underwent cone-beam µCT scans
demonstrated no signiﬁcant radiation damage in the animals
used [91].
Imaging system design may sometimes dictate animal
handling. For example, in MRI studies, no items comprising
ferromagnetic metals should be present within anMRI suite;
this inﬂicts limitations on equipment that may be needed for
small animals in a given investigation, such as monitoring
probes, catheters, needles, metal-containing sutures, or
implants. Although shielding from magnetic penetration
may be implemented for certain tools, MRI-compatible
alternatives are available for instruments that must be
present within the MRI suite and within close proximity to
the MRI unit [92].
Functional imaging modalities, which reveal physio-
logical changes in response to experimental interventions,
mandate stable homeostasis. *e administration of anaes-
thesia may inﬂuence key parameters, such as blood volume,
ﬂow, and oxygenation; therefore, these changes must be
acknowledged and compensated for when administering
anaesthetics, analgesics, ﬂuids, body temperature control,
blood pressure regulation, or artiﬁcial ventilation
[27, 93–95]. Other considerations when using small animal
models arise simply from their small size, which imposes the
need for specialised equipment. In experimental models, it is
important for stroke to be stimulated under sterile and
hygienic conditions to minimise the occurrence of wound
infections. It is crucial to verify that any neuroinﬂammation
that is identiﬁed using imaging techniques stems from is-
chaemia, rather than inadequate aseptic methods [96].
Administering suﬃcient anaesthesia for the duration of the
imaging scan, sustaining metabolic homeostasis via dedi-
cated monitoring equipment, and restricted access to the
animal during the imaging scan are also prominent aspects
that require consideration to ensure that the instruments
utilised do not generate image distortions or hazards to the
animals or researchers [92].
4.8. Potential Limitations in Imaging Vascular Remodelling.
Improving the interpretation of imaging data is an active
ﬁeld of research to overcome the functional limitations
present in various imaging techniques. For example, PET
produces high-resolution images that are subject to back-
ground noise in the data that must be corrected for. Imaging
vascular changes using contrast-enhanced methods expe-
riences similar issues. Contrast-enhanced imaging methods
rely on the distribution of molecules throughout the vas-
culature to be visualised. In ischaemic injury, vessel dis-
ruption directly aﬀects the distribution of contrast. Acutely,
this absence of contrast agents may contribute to the di-
agnosis of ischaemia; however, in long-term settings, the
remodelling itself may contribute to the absence of contrast
agents by means of vessel occlusion, haemostasis, or sub-
threshold quantities of contrast in these vessels, thus limiting
detection on image acquisition. *is disruption in blood
ﬂow is certainly not uncommon in ischaemic injury, and this
phenomenon has been previously demonstrated with the use
of ultrafast Doppler angiography to study coronary blood
ﬂow dynamics [97]. Cerebral blood volume is another
concern when assessing neurovascular remodelling because
an increase can represent either neoangiogenesis or vessel
dilatation [14]. Lack of deﬁnition is also an issue to consider
when imaging vasculature after injury. *e damaged vessels
may also allow the contrast agent to leak into the interstitial
space around the vessels, which can inevitably distort the
resulting images obtained by generating blurred images [98].
*us, in such cases, certain types of noise in the data could
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potentially represent vascular leakage or, comprising a more
positive outlook, could provide information on changes in
postinjury blood ﬂow dynamics.
One overarching aspect that may be worth considering
when interpreting images from the translation of preclinical
research to its application to humans is the age of animal
models used. In general, younger animal models are used for
research purposes simply because they are easier to manage
and incur lower laboratory costs; older animals would need
to be maintained for several months until the equivalent “old
age.” However, ischaemic injury in the form of stroke is a
much more common occurrence in elderly individuals
amongst humans. *e ischaemic penumbra also varies in
measurements of size and its incorporation into the
ischaemic core over time between young and old animals
[96]. As a result, it may be worth imaging small animals at
various time points into “older” age to inform the in-
terpretation of imaging results in preclinical models.
Whether the physiology and pathology of younger pre-
clinical models provide a suﬃcient platform to develop
eﬀective treatments in older humans is a point to consider in
future research.
4.9. Future Prospects. *e current trends in preclinical
imaging are progressing towards synergistic methods,
allowing for the simultaneous extraction of the beneﬁcial
characteristics of each individual modality, a broader range
of information that can be obtained from resulting images,
and thus, optimisation of diagnosis. It is diﬃcult to establish
a single imaging technique that is optimal in all cases, as this
will likely require a trade-oﬀ between diﬀerent parameters;
instead, multimodal techniques can be employed to take
advantage of the most optimal parameters. Furthermore,
with the data obtained from multiple imaging techniques, a
greater number of parameters may be integrated into or used
to conﬁrm mathematical models to shed further light on
physiological and pathological information [69, 73].
Amultimodal imaging systemwith the ability to perform
SPECT, bioluminescence imaging, and ﬂuorescence imag-
ing—referred to as the U-SPECT-BioFluo system—was
introduced to elucidate physiological and anatomical in-
formation within the body, speciﬁcally to target tumours. To
achieve this, mouse models were administered with both a
ﬂuorescent optical dye and radioactive agent to visualise
their molecular-level interactions within the body. *is
imaging system was originally introduced with speciﬁc
relevance to study tumourigenic angiogenesis, and similarly,
such a system could be employed to study the vascular
changes (which also involve angiogenesis, amongst other
cellular processes) following ischaemic injury (Figure 8)
[99]. On a similar note, another group developed a hex-
amodal imaging system that exploited a unique porphyrin-
phospholipid-coated type of nanoparticle. *ese nano-
particulate agents can be utilised to retrieve information
from six diﬀerent imaging modalities that comprise this
system: upconversion, ﬂuorescence, photoacoustic, PET,
CT, and Cherenkov luminescence imaging [100]. Highly
integrated systems such as this show great promise and
feasibility for providing information that may not be
achievable with single or dual imaging modalities. Multi-
modal neuroimaging hence represents the foundation for
advancing postischaemic restorative therapies. Combina-
torial techniques can ultimately be implemented to achieve a
more needs-based and personalised approach in medicine
and healthcare.
Novel tracers that target diﬀerent molecular pathways
and can be utilised with existing imaging systems are also
continuously under investigation. For example, the newly
characterised PET tracer [18F]glycoprotein-1 ([18F]GP1) has
been demonstrated to elucidate regions of platelet aggre-
gation and thrombi in cynomolgus monkeys. Small venous
and arterial thrombi were clearly and simply visualised in
real time, and the tracer exhibited rapid blood clearance,
raising the possibility of imaging ischaemia-related vascular
changes in humans using [18F]GP1 (Figure 9) [101]. In
addition, another group demonstrated the feasibility of a
dual optical and PET/CT tracer for (a) noninvasive in vivo
imaging of activated macrophages and vascular in-
ﬂammatory activity in atherosclerotic plaques in mouse
models and (b) visualisation of activated macrophages in
human carotid plaque tissues, based on the activity of
cysteine cathepsins [102].
Developments in MRI systems that may be useful in
cases of ischaemia are also worth mentioning here. Four-
dimensional (4D) ﬂow MRI has been demonstrated to be
useful for the evaluation of neurovascular haemodynamics
and cerebral blood ﬂow [103, 104]. Although long acqui-
sition times (approx. 5–20min) and a spatial resolution that
is insuﬃcient to capture small-vessel haemodynamics rep-
resent considerable technical limitations, 4D ﬂow MRI
comes with the beneﬁt of evading the necessity for gado-
linium contrast agents [105]. To achieve superior image
contrast, MRI-based quantitative susceptibility-weighted
imaging oﬀers a way to facilitate the delineation of neural
structures with the added advantage of quantiﬁcation of
magnetic properties in the brain [83]. Ultimately, preclinical
imaging is performed with the aim of translating ﬁndings to
clinical practice. Given the fact that the most common
preclinical imaging techniques are MRI followed by PET, as
identiﬁed in this systematic literature review, their direct
combination in dedicated PET/MRI systems can prove to be
advantageous for providing complementary functional and
structural data. *is would be advantageous for studying
ongoing vascular changes; however, technical developments
are warranted to facilitate accurate quantiﬁcation and im-
proved spatiotemporal resolution [106, 107].
*rough its wide-ranging applications, preclinical im-
aging generously lends itself to translational approaches
from small animals to humans.*e ability to visualise tissues
and organs inﬂuences the precision and accuracy of di-
agnosis, staging, treatment planning, and treatment re-
sponse evaluation. MRI, PET, SPECT, CT, and ultrasound
are commonly used in clinical practice for various imaging
purposes. Although optical imaging modalities are relatively
not as frequently implemented in the clinic, they are in-
creasingly garnering attention for clinical translation [108].
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(a)
(b)
Figure 8: Images of a mouse with a 4T1-luc+ tumour. Bioluminescence images were acquired following D-luciferin injections; ﬂuorescence and
SPECT images were acquired following multimodal tracer [111In]-RGD-MSAP injections. (a) U-SPECT-BioFluo bioluminescence images with
and without median ﬁlter applied, ﬂuorescence images with high and low threshold applied, and SPECT image. (b) IVIS bioluminescence and
ﬂuorescence images. SPECT, single-photon emission computed tomography; IVIS, in vivo imaging system.*is ﬁgure is published in [99], which
is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0).
(a)
0.20
0.15
0.10%
 ID
/g
0.05
0.00
0 10 20 30
Time (min)
40 50 60
M1-venous
M1-arterial
M1-blood
M2-venous
M2-arterial
M2-blood
(b)
Figure 9: (a) [18F]GP1 PETimage of cynomolgusmonkeyswith arterial and venous catheters that were inserted in the right carotid artery and vena
cava, respectively (maximum-intensity projection 0–60min). Both arterial and venous thrombi exhibited tracer uptake. (b) [18F]GP1 time-activity
curves of thrombus uptake and blood clearance in monkeys 1 (displayed in (a)) and 2. [18F]GP1, [18F]glycoprotein-1; PET, positron emission
tomography;M1,monkey 1;M2,monkey 2; %ID/g, percentage injected dose per gram.*is researchwas originally published by Lohrke et al. [101].
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Multimodal Platforms is a programme dedicated to de-
veloping, optimising, and validating imaging methods for
rapid clinical translation. In particular, this network focusses
on early-stage imaging using multiple common modalities
in combination with an optical imaging modality; this
combination may facilitate a quicker progression of optical
imaging modalities to clinical trials [109, 110].
Furthermore, multidisciplinary collaboration can prove
to enhance the value of imaging technology in translating
preclinical animal models to clinical settings. For example,
point-of-care technology is emerging as the future direction
for clinical applications of imaging to enhance patients’
experiences and decrease associated expenses. *e most
signiﬁcant advantage of point-of-care medical imaging is the
capacity to provide instant information to guide immediate
clinical management decisions, as it acts as a ﬁrst-line tool to
screen for acute medical problems, particularly in resource-
limited settings [60]. Ultimately, optimal medical and mo-
lecular imaging methods may contribute to more accurate
diagnoses at earlier disease stages and prior to and during
surgical operations; in due course, these methods are an-
ticipated to enhance therapeutic outcomes in patients.
5. Conclusions
*eﬁeld of neuroimaging has augmented our understanding
of the mechanisms of ischaemic trauma, and a variety of
imaging techniques are particularly helpful for observing
subsequent vascular remodelling within the brain. Appro-
priate combinations of imaging modalities incorporating
biomarkers of blood ﬂow, energy ﬂuctuations, and neuro-
vascular breakdown can potentially elucidate optimal per-
spectives of postischaemic reorganisation.
*is review is a systematic study and analysis of the
literature published between 2008 and 2018 regarding
preclinical in vivo imaging biomarkers for postischaemia
neurovascular remodelling. *e search identiﬁed 35 peer-
reviewed research articles, which predominantly reported on
the use of MRI or PET, although other imaging modalities
were also utilised. *ere remain critical gaps in our
knowledge within the ﬁeld of restorative therapy for neu-
rological pathologies, such as traumatic brain injury and
ischaemia; amongst them, being able to detect vascular
remodelling noninvasively and observe its evolution
through stages of vascular recovery is an important aspect.
*e push towards molecular imaging has promoted the
development of biological target-speciﬁc tracers to reveal the
physiological and pathological mechanisms within the brain.
Concurrently, the prospect of multimodality clinical im-
aging with its uniﬁcation of anatomical and functional in-
formation holds superior potential in expanding our
understanding of neurovascular organisation and disease
activity.
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